Huazhong Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Huazhong Liu has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Zhen Lin
Department of Applied Chemistry, Guangdong Ocean University, School of Chemistry and Environment, Zhanjiang, 524088, China
4 shared publicationsJiayi Wu
Department of Applied Chemistry, Guangdong Ocean University, School of Chemistry and Environment, Zhanjiang, 524088, China
3 shared publicationsPing Luo
Department of Applied Chemistry, Guangdong Ocean University, School of Chemistry and Environment, Zhanjiang, 524088, China
3 shared publicationsFangping Li
College of Chemistry & Environmental Science, Guangdong Ocean University, Zhanjiang, 524088, China
2 shared publicationsXiaohui Tan
College of Chemistry & Environmental Science, Guangdong Ocean University, Zhanjiang, 524088, China
2 shared publicationsYu Zhang
College of Chemistry & Environmental Science, Guangdong Ocean University, Zhanjiang, 524088, China
2 shared publications
Latest Publications
- 12 May 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 366, 152504
Structural characterization and anticancer enhancement of selenized squid ink glycosaminoglycan nanoparticles
- 12 May 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 366, 152504
Structural characterization and anticancer enhancement of selenized squid ink glycosaminoglycan nanoparticles
- 17 April 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 363, 152103
Structural characterization of a glycosaminoglycan sulfate from Sepia esculenta ink, and its apoptosis induction in MDA-MB-231 cells via miR-18a-5p/ORAI3 pathway mediated intracellular calcium overload
- 17 April 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 363, 152103
Structural characterization of a glycosaminoglycan sulfate from Sepia esculenta ink, and its apoptosis induction in MDA-MB-231 cells via miR-18a-5p/ORAI3 pathway mediated intracellular calcium overload
- 2 January 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 293, 139454
Inhibition of urate induced pyroptosis and reabsorption transporters overexpression in human renal tubular epithelial cells by low molecular weight fucoidan, as well as its anticoagulation and antioxidation
- 2 January 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 293, 139454
Inhibition of urate induced pyroptosis and reabsorption transporters overexpression in human renal tubular epithelial cells by low molecular weight fucoidan, as well as its anticoagulation and antioxidation
- 18 January 2023
- Published by Elsevier in Science of The Total Environment
- Vol. 869, 161730
Toxicologic effect of short-term enrofloxacin exposure on brain of Carassius auratus var. Pengze
- 18 January 2023
- Published by Elsevier in Science of The Total Environment
- Vol. 869, 161730
Toxicologic effect of short-term enrofloxacin exposure on brain of Carassius auratus var. Pengze
- 1 January 2022
- Published by Elsevier in Carbohydrate Polymers
- Vol. 276, 118715
Effects of a sulfated glycosaminoglycan from Sepia esculenta ink on transcriptional and metabolic profiles of Saccharomyces cerevisiae
- 1 January 2022
- Published by Elsevier in Carbohydrate Polymers
- Vol. 276, 118715
Effects of a sulfated glycosaminoglycan from Sepia esculenta ink on transcriptional and metabolic profiles of Saccharomyces cerevisiae
- Open Access
- 23 April 2021
- Published by MDPI AG in Marine Drugs
- Vol. 19 (5) , 238
Fucoidan from Laminaria japonica Inhibits Expression of GLUT9 and URAT1 via PI3K/Akt, JNK and NF-κB Pathways in Uric Acid-Exposed HK-2 Cells
This work aimed to investigate the effect of fucoidan (FPS) on urate transporters induced by uric acid (UA). The results showed that UA stimulated the expression of glucose transporter 9 (GLUT9) and urate transporter 1 (URAT1) in HK-2 cells, and FPS could reverse the effect. Moreover, UA could activate NF-κB, JNK and PI3K/Akt pathways, but both pathway inhibitors and FPS inhibited the UA-induced activation of these three pathways. These data suggested that FPS effectively inhibited the expression induction of reabsorption transporters URAT1 and GLUT9 by UA, through repressing the activation of NF-κB, JNK and PI3K/Akt signal pathways in HK-2 cells. The in vitro research findings support the in vivo results that FPS reduces serum uric acid content in hyperuricemia mice and rats through inhibiting the expression of URAT1 and GLUT9 in renal tubular epithelial cells. This study provides a theoretical basis for the application of FPS in the treatment of hyperuricemia.
- 23 April 2021
- Published by MDPI AG in Marine Drugs
- Vol. 19 (5) , 238
Open AccessFucoidan from Laminaria japonica Inhibits Expression of GLUT9 and URAT1 via PI3K/Akt, JNK and NF-κB Pathways in Uric Acid-Exposed HK-2 Cells
This work aimed to investigate the effect of fucoidan (FPS) on urate transporters induced by uric acid (UA). The results showed that UA stimulated the expression of glucose transporter 9 (GLUT9) and urate transporter 1 (URAT1) in HK-2 cells, and FPS could reverse the effect. Moreover, UA could activate NF-κB, JNK and PI3K/Akt pathways, but both pathway inhibitors and FPS inhibited the UA-induced activation of these three pathways. These data suggested that FPS effectively inhibited the expression induction of reabsorption transporters URAT1 and GLUT9 by UA, through repressing the activation of NF-κB, JNK and PI3K/Akt signal pathways in HK-2 cells. The in vitro research findings support the in vivo results that FPS reduces serum uric acid content in hyperuricemia mice and rats through inhibiting the expression of URAT1 and GLUT9 in renal tubular epithelial cells. This study provides a theoretical basis for the application of FPS in the treatment of hyperuricemia.
- Open Access
- 28 March 2018
- Published by MDPI AG in Marine Drugs
- Vol. 16 (4) , 106
A Potential Adjuvant Agent of Chemotherapy: Sepia Ink Polysaccharides
Sepia ink polysaccharide (SIP) isolated from squid and cuttlefish ink is a kind of acid mucopolysaccharide that has been identified in three types of primary structures from squid (Illex argentinus and Ommastrephes bartrami), cuttlefish Sepiella maindroni, and cuttlefish Sepia esculenta ink. Although SIP has been proved to be multifaceted, most of the reported evidence has illuminated its chemopreventive and antineoplastic activities. As a natural product playing a role in cancer treatment, SIP may be used as chemotherapeutic ancillary agent or functional food. Based on the current findings on SIP, we have summarized four topics in this review, including: chemopreventive, antineoplastic, chemosensitive, and procoagulant and anticoagulant activities, which are correlative closely with the actions of anticancer agents on cancer patients, such as anticancer, toxicity and thrombogenesis, with the latter two actions being common causes of death in cancer cases exposed to chemotherapeutic agents.
- 28 March 2018
- Published by MDPI AG in Marine Drugs
- Vol. 16 (4) , 106
Open AccessA Potential Adjuvant Agent of Chemotherapy: Sepia Ink Polysaccharides
Sepia ink polysaccharide (SIP) isolated from squid and cuttlefish ink is a kind of acid mucopolysaccharide that has been identified in three types of primary structures from squid (Illex argentinus and Ommastrephes bartrami), cuttlefish Sepiella maindroni, and cuttlefish Sepia esculenta ink. Although SIP has been proved to be multifaceted, most of the reported evidence has illuminated its chemopreventive and antineoplastic activities. As a natural product playing a role in cancer treatment, SIP may be used as chemotherapeutic ancillary agent or functional food. Based on the current findings on SIP, we have summarized four topics in this review, including: chemopreventive, antineoplastic, chemosensitive, and procoagulant and anticoagulant activities, which are correlative closely with the actions of anticancer agents on cancer patients, such as anticancer, toxicity and thrombogenesis, with the latter two actions being common causes of death in cancer cases exposed to chemotherapeutic agents.